brain injury
Top Five Articles on 360Dx Last Week: Roche, BARDA TBI Partnership; Lumos Dx Expansion Plan; More
Last week, readers were most interested in a story about Roche and BARDA teaming up to develop diagnostic tests for traumatic brain injuries.
BioMérieux TBI Immunoassay Gets FDA 510(k) Clearance
The test detects two serum biomarkers of mild traumatic brain injury on the firm's Vidas 3 and Vidas Kube systems.
Danaher, Johns Hopkins Partner to Develop Methods for Detecting Mild TBI
Researchers at Johns Hopkins will use technology from Beckman Coulter Diagnostics to evaluate new blood-based biomarkers.
BioMérieux Gets CE Mark for Traumatic Brain Injury Immunoassay
The test results can be used to rule out intracranial lesions, potentially eliminating the need for head CT scans.
Abbott Gains FDA Clearance for Lab-Based TBI Test
The assay will run on Abbott's Alinity I instrument and is intended to help evaluate patients with mild concussions.
Jul 29, 2021
Jul 13, 2021
InfanDx Raises €4M in Series A Financing Round
Jan 27, 2021
Jul 1, 2020
NanoDiagnostics Closes $18M Series C Round
Sep 10, 2019